Cargando…
Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
BACKGROUND: Although a pathologic complete response (pCR) after neoadjuvant chemotherapy is associated with favourable outcomes, a small proportion of patients with pCR have recurrence. This study was designed to identify factors predictive of recurrence in patients with pCR. METHODS: A total of 449...
Autores principales: | Tanioka, M, Shimizu, C, Yonemori, K, Yoshimura, K, Tamura, K, Kouno, T, Ando, M, Katsumata, N, Tsuda, H, Kinoshita, T, Fujiwara, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920023/ https://www.ncbi.nlm.nih.gov/pubmed/20606681 http://dx.doi.org/10.1038/sj.bjc.6605769 |
Ejemplares similares
-
Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer
por: Hirata, T, et al.
Publicado: (2009) -
Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017) -
Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response
por: Asano, Junichi, et al.
Publicado: (2013) -
Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
por: Yonemori, K, et al.
Publicado: (2009) -
Primary Yolk Sac Tumor of the Omentum: A Case Report and Literature Review
por: Harano, Kenichi, et al.
Publicado: (2012)